Study Findings on Acute Cholecystitis Are Outlined in Reports from Sichuan University (Clinical Observation of Ceftriaxone Sodium and Xiaoyan Lidan Tablets In the Treatment of Acute Cholecystitis).

A study conducted at Sichuan University in China examined the clinical efficacy and safety of using ceftriaxone sodium and Xiaoyan Lidan tablets to treat acute cholecystitis. The study included 78 individuals with acute cholecystitis who were divided into two groups: one receiving ceftriaxone sodium alone and the other receiving a combination of Xiaoyan Lidan tablets and ceftriaxone sodium. The combination group showed a higher overall response rate and shorter resolution times for symptoms such as epigastric pain, fever relief, nausea, and vomiting compared to the monotherapy group. Additionally, the combination group had lower levels of inflammatory markers and similar rates of adverse reactions. The researchers concluded that the combination treatment was effective and safe in reducing inflammation and promoting patient recovery. [Extracted from the article]